Nicotinic acetylcholine receptor at neuromuscular junction — Drug Target

All drugs that target Nicotinic acetylcholine receptor at neuromuscular junction — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Neuromuscular blocking agent

Marketed (1)

• injection of NMBA · Fondation Ophtalmologique Adolphe de Rothschild · Neuromuscular blocking agent · Anesthesia
  NMBA (neuromuscular blocking agent) injection causes temporary paralysis of skeletal muscles by blocking acetylcholine at the neuromuscular junction.